ECOSOC, UBERISATION OF HEALTH: what new economic and collaborative model can we consider ?
oumaima reddadi
le 28/02/2018 à 11:34 Citer ce message
Committee : ECOSOC
Problematic : UBERISATION OF HEALTH: what new economic and collaborative model can we consider ?
Delegation: UK
Technology has been permeating almost every aspect of our lives, until recent years the medical field has been largely unaffected by the rapid pace of technological innovation that is characteristic of the Digital.
Therefore the ubiquity of technology is beginning to extend into the medical field. Advances in medical technology are changing medicine by giving physicians more information — as well as better, more specific data.
Indeed for some years now we have been able to notice the dematerialization of medical information with the integration of technologies such as prescription assistance software, professional secure messaging, appointment management or home visiting software and especially the computerized medical file. . This can be explained in particular by the dissatisfaction of the patient, more and more demanding, especially on the saving of time. This requirement leads, for example, to the emergence and development of platforms providing medical advice such as Doctissimo or mytomorrow.
The UK government recently approved Lord Saatchi's Medical Innovation Bill, starting next year we will be able to grant legal protection for doctors who suggest new, unapproved drugs to their patients. Let’s explain why . There are about 1 million people every year in Europe that hear from their doctor that they do not have any options, Now, most of those patients have children and relatives who know quite well their way on the internet, but it's just very difficult to go through the medical jargon. New platforms such as mytommorow in UK specify what kind of clinical trials are running in what part of the world, under what regulations and for what disease. The drugs provided by myTomorrows are in the second or third phase of testing: they have been tested in laboratories for 6 or 7 years, but not extensively. And by putting patients in contact with solutions from all over the world, the website works as a multinational database of out-of-market drugs.
The delegation of UK Supports the start-ups in the sharing economy and encourages experimentation and innovation. The main goal is to permit the research, collect and analysis of data to improve the understanding of public health challenges, and come up with answers to public health problems by promoting the use of technological resources.
Problematic : UBERISATION OF HEALTH: what new economic and collaborative model can we consider ?
Delegation: UK
Technology has been permeating almost every aspect of our lives, until recent years the medical field has been largely unaffected by the rapid pace of technological innovation that is characteristic of the Digital.
Therefore the ubiquity of technology is beginning to extend into the medical field. Advances in medical technology are changing medicine by giving physicians more information — as well as better, more specific data.
Indeed for some years now we have been able to notice the dematerialization of medical information with the integration of technologies such as prescription assistance software, professional secure messaging, appointment management or home visiting software and especially the computerized medical file. . This can be explained in particular by the dissatisfaction of the patient, more and more demanding, especially on the saving of time. This requirement leads, for example, to the emergence and development of platforms providing medical advice such as Doctissimo or mytomorrow.
The UK government recently approved Lord Saatchi's Medical Innovation Bill, starting next year we will be able to grant legal protection for doctors who suggest new, unapproved drugs to their patients. Let’s explain why . There are about 1 million people every year in Europe that hear from their doctor that they do not have any options, Now, most of those patients have children and relatives who know quite well their way on the internet, but it's just very difficult to go through the medical jargon. New platforms such as mytommorow in UK specify what kind of clinical trials are running in what part of the world, under what regulations and for what disease. The drugs provided by myTomorrows are in the second or third phase of testing: they have been tested in laboratories for 6 or 7 years, but not extensively. And by putting patients in contact with solutions from all over the world, the website works as a multinational database of out-of-market drugs.
The delegation of UK Supports the start-ups in the sharing economy and encourages experimentation and innovation. The main goal is to permit the research, collect and analysis of data to improve the understanding of public health challenges, and come up with answers to public health problems by promoting the use of technological resources.
Répondre à ce message
